Work

Intangible-Specific Non-Financial Disclosures and Cost of Capital: Evidence from the U.S. Pharmaceutical Industry

Year: 2014
Type: preprint
Abstract: This paper studies the impact of the forward looking intangibles-specific non-financial and textual disclosures on the annual reports (including MD&A, etc.) of 25 biggest Pharmaceutical firms listed in the United States. Using a mixed research method the information from the annual reports are categorized into two sections, (i.) ‘existence of disclosure’, and (ii.) ‘quality of disclosure.’ Evidence from this study shows that, overall, the intangibles-specific non-financial and textual information does not have any explanatory power. However, when the information is sub-divided into communication types (Strategy, Human Resources, etc.) then Customer & Market and Innovation & IPR are found to explain the expected stock returns — which is a measure of a firm’s cost of capital.
Language: English
Open Access status: green
OpenAlex ID: W2336682121
Cites: 21
Cited by:
Related to: 10